Logo for 4D Molecular Therapeutics Inc

4D Molecular Therapeutics Investor Relations Material

Latest events

Logo for 4D Molecular Therapeutics Inc

Study Update

4D Molecular Therapeutics
Logo for 4D Molecular Therapeutics

Q4 2023

29 Feb, 2024
Logo for 4D Molecular Therapeutics

Study Update

5 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from 4D Molecular Therapeutics Inc

Access all reports
4D Molecular Therapeutics Inc. (FDMT) is a clinical-stage biotherapeutics company engaged in the development of genetic medicines using a proprietary therapeutic vector evolution platform. The company is focused on addressing serious unmet medical needs across three main therapeutic areas: ophthalmology, cardiology, and pulmonology. Its portfolio includes genetic medicine product candidates in various stages of clinical trials. FDMT is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.